The MS Alphabet: EVP, Exacerbations, Estriol and more ‘E’ words
July 5, 2017
Hair dyes, relaxers tied to raised breast cancer risk
July 6, 2017
Show all

Cancer Treatment with Biomarkers

A new cancer drug targets biomarkers that don’t depend of where cancer is located in the body.

Laura Dixon has a long history with cancer.

She was diagnosed with colon cancer in 1996, pancreatic cancer in 2013, and ovarian and endometrial cancer in 2014. Her treatment included several surgeries and a variety of chemotherapy drugs.

In 2015, a tumor in her liver turned out to be a pancreatic cancer recurrence.

But things were different this time.

The 49-year-old resident of Columbus, Ohio, had access to a clinical trial and a previously approved cancer drug called Keytruda. The clinical trial took place at The Ohio State University Comprehensive Cancer Center.

Read full article: Cancer Treatment with Biomarkers

Read Full Article: Cancer Treatment with Biomarkers

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.